Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 10/26/2023 Orion Group Interim Report January–September 2023
- 9/20/2023 Change in Orion Group's Half-Year Financial Report 2024 publication date
- 9/4/2023 24 000 Orion Corporation A shares converted into B shares
- 8/22/2023 Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture
Press releases
- 11/21/2023 Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database
- 11/20/2023 Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)
- 11/15/2023 Orion Research Foundation grants EUR 1,112,000 for research in 2024
- 10/16/2023 Orion publishes Interim Report for January–September 2023 on Thursday 26 October 2023
